Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNCOVERED: Analyst day | History Defined

Workday AI Push Signals Durable Growth And Sharper Margins Ahead

Workday (NASDAQ:WDAY) outlined stronger-than-expected operating margins, rising free cash flow, and accelerating artificial intelligence adoption at its Analyst Day, prompting optimism about long-term growth.

Benzinga · Sep 17, 2025

Analysts Cheer Workday's Better Than Feared Q2 Amid Macro Concerns

Workday, Inc (NASDAQ:WDAY) clocked 21.9% revenue growth in Q2 to $1.54 billion, which beat average analyst estimates. The subscription revenues of $1.37 billion were up 22.8%. Workday reported EPS of $0.83, which beat average analyst estimates. Workday reported solid 2Q23 results highlighted with an uncertain macro backdrop pressuring sales much less than feared, Needham analyst…

Benzinga · Aug 26, 2022

3 FedEx Analysts React To Mixed Q4 Earnings: 'Analyst Day Anticipation Building'

FedEx Corporation (NYSE: FDX) shares traded higher by 7% on Friday after the conglomerate reported fiscal fourth-quarter earnings that were better than analysts had feared.

Benzinga · Jun 24, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Why This Analyst Came Away 'Incrementally More Constructive' From AMD's Analyst Day

Advanced Micro Devices, Inc. (NASDAQ: AMD) held its Analyst Day event on Thursday, when it issued commentary on financials and product pipeline.

Benzinga · Jun 10, 2022

Needham Is 'More Optimistic' on WalkMe's Value Proposition After Q1 Performance - Read Why

Needham analyst Scott Berg maintained WalkMe Ltd (NASDAQ:WKME) with a Buy and lowered the price target from $40 to $20 (132.3% upside) post Q1 FY22 results. Berg attended WalkMe's first Analyst Day, becoming more optimistic about its value proposition and ability to become a more strategic partner with customers. Also Read: Here's How KeyBanc Rates WalkMe Post…

Benzinga · May 25, 2022

Why This Analyst Believes Ameresco Is Oversold

While Ameresco Inc.’s (NYSE: AMRC) shares are down due to the disappointing BBB legislative and rates, as well as leverage factors and concerns around its delayed Analyst Day, according to BofA Securities the company offers “superior EBITDA growth (high-teens)” and the potential of a po

Benzinga · Feb 2, 2022

Coverage From

Benzinga

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

7,790 stories

IPO

3,278 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.